SGD Pharma to participate to the Road to CPHI Milano.
The Road To CPHI Milano is a new adventure – taking place in the run-up to CPhI Worldwide 2020 in Milan. From September 14 to October 9, Pharma’s Almanac will be discovering the future of healthcare on a 7,000+ mile journey around 25 countries – and companies - in Europe.
In February and March, SGD Pharma made several donations of protective equipment like masks, goggles and other protective gears to Zhanjiang local government and Zhanjiang Red Cross, the city where one of our plant is located.
This action was taken to locally support the collective effort of China and the government during the fight against COVID-19.
Zhanjiang city, represented by its Executive Deputy Mayor, expressed its gratitude for SGD Pharma’s help during a meeting at Zhanjiang People’s Hall.
Together, we’re strong!
color:#313131;mso-ansi-language:EN-US" xml:lang="EN-US">A number of events in the pharmaceutical and life science industries are being affected due to the Coronavirus disease (COVID-19). Our partner Orientation Marketing, a specialist pharmaceutical and life science media and marketing agency, is keeping an updated list of those events, trade shows and conferences affected so you can alter your travelling plans.
In the January / February 2020 issue of Glass Worlwide magazine, Carole Grassi discusses SGD Pharma’s innovative solutions for implementing aseptic filling with ready-to-use moulded glass vials. Click here to read the complete article.
At SGD Pharma, we have the strong conviction that glass packaging can significantly contribute to a safer and better environment;
Glass packaging offers exceptional benefits:
• Sustainable. Reduced environmental impact over other traditional packaging methods.
• Chemically Neutral. Prevents interaction between packaging material and drug product.
"The global CBD regulatory landscape is evolving rapidly. Our dedicated team has developed a full regulatory package to provide CBD producers with peace of mind that their packaging for new CBD oils complies with the necessary regulations, demonstrated by our CRC certifications and US and European Pharmacopoeia compliance.
EMBELIA continues to evolve and acquires a leading logistics tool to create the necessary conditions for growth and development in a demanding market in terms of supply, quality and service. The Sucy-en-Brie storage site was moved this summer to Savigny-sur-Clairis.
Covering an area of 8000 m², the Savigny-sur-Clairis site has many advantages:
Use of the parenteral route of administration has risen sharply in recent years, with parenteral drugs now representing approximately 32% (by volume) of the global market [1]. Parenteral drug delivery, via injection or infusion, is essential for many biologics but is also commonly used for small molecules, low solubility drugs and delivery of nutritional and vitamin therapies.
